Valeo Pharmainc (VPH.CN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.660 unch (unch) 03/28/22 [CNSX]
N/A x N/A N/A x N/A
Post-market 0.660 unch (unch) -
Fiscal Year End Date: 10/31
(Values in thousands)
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 626 | 637 | 652 | 751 | 630 |
| Accounts receivable | 836 | -476 | 1,430 | -1,204 | 1,202 |
| Other Working Capital | 4,262 | 1,642 | 6,466 | 4,063 | 3,213 |
| Other Operating Activity | -5,273 | -5,118 | -6,917 | -6,280 | -6,304 |
| Operating Cash Flow | $451 | $-3,315 | $1,631 | $-2,670 | $-1,259 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -40 | -50 | -29 | -111 |
| Purchase Sale Intangibles | 0 | 1,327 | 275 | -5,000 | 0 |
| Other Investing Activity | 0 | 1,327 | 275 | 0 | 0 |
| Investing Cash Flow | $0 | $1,287 | $225 | $-5,029 | $-111 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -7 | -564 | 680 | 1,490 | 1,300 |
| Debt Repayment | -55 | -60 | -60 | -60 | -57 |
| Common Stock Issued | N/A | N/A | N/A | 3,920 | 0 |
| Other Financing Activity | -186 | -216 | -160 | -297 | 0 |
| Financing Cash Flow | $-248 | $-840 | $460 | $5,053 | $1,243 |
| Exchange Rate Effect | 32 | 173 | -233 | 372 | -216 |
| Beginning Cash Position | 6,890 | 9,585 | 7,502 | 9,776 | 10,119 |
| End Cash Position | 7,125 | 6,890 | 9,585 | 7,502 | 9,776 |
| Net Cash Flow | $203 | $-2,868 | $2,316 | $-2,646 | $-127 |
| Free Cash Flow | |||||
| Operating Cash Flow | 451 | -3,315 | 1,631 | -2,670 | -1,259 |
| Capital Expenditure | N/A | -40 | -50 | -5,029 | -111 |
| Free Cash Flow | 451 | -3,355 | 1,581 | -7,699 | -1,370 |